Rare diseases
Investigational molecules
Locations
73c Route 31 North, 08534-3601, United States
Zydus Therapeutics Inc. is active in hepatology through clinical research focused on Primary Biliary Cholangitis, a chronic autoimmune liver disease affecting bile duct function and liver biochemistry.
The sponsor’s work in this area centers on biochemical response and liver-related disease control within autoimmune liver disorders.
Zydus Therapeutics Inc. runs clinical trials in conditions such as Primary biliary cholangitis, Amyotrophic lateral sclerosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
BelgiumSafety and Efficacy of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis: A Long‑Term Randomized Placebo‑Controlled Study
BulgariaStudy on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis
IcelandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
